0001181431-13-033364.txt : 20130606 0001181431-13-033364.hdr.sgml : 20130606 20130606215942 ACCESSION NUMBER: 0001181431-13-033364 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130604 FILED AS OF DATE: 20130606 DATE AS OF CHANGE: 20130606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 7 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8424 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 7 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HODGMAN JOHN CENTRAL INDEX KEY: 0001212689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 13898775 MAIL ADDRESS: STREET 1: C/O IMMERSION CORP STREET 2: 801 FOX LN. CITY: SAN JOSE STATE: CA ZIP: 95131 4 1 rrd382726.xml FORM 4 X0306 4 2013-06-04 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001212689 HODGMAN JOHN 215 FIRST STREET, SUITE 7 CAMBRIDGE MA 02412 1 0 0 0 Common Stock 2013-06-04 4 A 0 1000 0 A 4333 D Non-Qualified Stock Option (right to buy) 34.9200 2013-06-04 4 A 0 20000 0 A 2014-06-04 2023-06-04 Common Stock 20000 20000 D On June 6, 2013, Sarepta Therapeutics, Inc., a Delaware corporation, became the successor of Sarepta Therapeutics, Inc., an Oregon corporation, pursuant to a merger. The merger had the effect of changing the state of incorporation of Sarepta Therapeutics, Inc. from Oregon to Delaware, but did not alter the proportionate interests of security holders. Grant of restricted stock, which shall vest in full on the anniversary date of the grant. This option will vest at a rate of 25% annually over four years beginning on the first anniversary of the date of grant. By: David Tyronne Howton For: John Hodgman 2013-06-06